According to a comprehensive analysis by Future Market Insights (FMI), the global hernia mesh devices market is poised for steady growth, with an estimated compound annual growth rate (CAGR) of 3.4% during the forecast period. The market, valued at approximately USD 4.6 billion in 2022, is projected to reach USD 6.5 billion by 2032, reflecting strong demand and ongoing advancements in medical technology.
The growth of the hernia mesh market is primarily driven by the increasing prevalence of inguinal hernias, which represent 80% of all hernia cases worldwide. Inguinal hernias are ten times more common in men than in women, contributing significantly to the global healthcare burden. This rising prevalence is a key factor propelling the demand for innovative and effective hernia mesh devices, aimed at improving treatment outcomes and enhancing patient quality of life.
“Hernia mesh devices play a critical role in addressing the growing cases of inguinal hernias, a condition that affects millions worldwide,” said FMI. “The market is seeing a surge in demand for advanced, patient-centric solutions that improve surgical outcomes and reduce recurrence rates.”
North America, in particular, is set to experience significant growth throughout the forecast period, with a projected CAGR of 3.4%. The region benefits from favorable reimbursement policies, which encourage patients to opt for laparoscopic surgery. With comprehensive payment codes and industry-wide support, North America continues to lead in hernia mesh adoption. Technological innovations, such as new products like TELA Bio, are further boosting the market’s revenue potential in the region.
As the hernia mesh devices market evolves, stakeholders across the healthcare industry stand to benefit from ongoing advancements that improve patient care. The increasing focus on technological innovation and patient-centric solutions ensures that the hernia mesh market will continue to grow, providing better options for both healthcare providers and patients alike.
“Despite the 90% dominance of synthetic mesh in the Hernia Mesh device market, the biological mesh-based hernia devices can reap significant market revenue in the forthcoming years” comments an analyst at Future Market Insights.
Key Takeaways: Hernia Mesh Devices Market from 2022 to 2032
- The global hernia mesh devices market was valued at USD 4.6 billion in 2022 and is expected to reach USD 6.5 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 3.4%.
- Inguinal hernias are projected to remain the most common type, accounting for roughly 80% of all hernia procedures.
- The United States is anticipated to hold the largest market share, exceeding 34% by 2032. This makes it a prime target market for hernia mesh device manufacturers, particularly those specializing in synthetic mesh.
- Synthetic mesh devices are expected to see strong growth within the US market.
Dive Deep into the Market Trends: Access the Full Hernia Mesh Devices Market Report
Hernia Mesh Devices Market: Competition Insights
Most of the key players in hernia mesh devices market have been focusing on obtaining approvals from regulatory authorities. The key companies operating in the Hernia Mesh Devices market include Medtronic plc, Ethicon, and W. L. Gore and Associates, Inc., Atrium Medical Technologies, B. Braun Melsungen AG, PRIMEQUAL SA, Becton, Dickinson, and Company, Deep Blue Medical Inc., Dipromed Srl, BioCer Entwicklungs-GmbH, Betatech Medical, Sinolinks Medical Innovation, Inc, Aspide Medical S.A.S., Meril Life Sciences Pvt. Ltd., Herniamesh Srl., Changzhou Medical Equipment General Factory Co., Ltd, Gem Srl, SAMYANG HOLDING CORPORATION, Katsan Katgut Sanayi Ve Ticaret Anonim Sirketi, Novus Scientific AB.
The key recent developments of Hernia Mesh Devices manufacturers are as follows:
- Novus Scientific AB received FDA approval in March 2020 for TIGR Matrix Surgical Mesh, which is indicated for use in procedures involving soft tissue repairs, such as hernia repair or other soft tissue-related defects.
- Becton, Dickinson, and Company received FDA clearance in July 2020 for 3DMax MID Anatomical Mesh, which is indicated for use in soft tissue reinforcement and inguinal hernia repair.
- Deep Blue Medical Inc. received FDA approval to begin selling its new hernia mesh product in August 2020. Because of the product’s promising sales prospects, the company recently announced that investors have invested USD 3.4 million in the company.
Key Segments:
Key Segments Covered in Hernia Mesh Devices Market Survey
Hernia Mesh Devices Market by Mesh Type:
- Biological Mesh
- Synthetic Mesh
Hernia Mesh Devices Market by Hernia Type:
- Inguinal Hernia
- Incisional Hernia
- Femoral Hernia
- Others
Hernia Mesh Devices Market by Region:
- North America Hernia Mesh Devices Market
- Latin America Hernia Mesh Devices Market
- Europe Hernia Mesh Devices Market
- South Asia Hernia Mesh Devices Market
- East Asia Hernia Mesh Devices Market
- Oceania Hernia Mesh Devices Market
- Middle East & Africa Hernia Mesh Devices Market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube